IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18 / STAT3 pathway
Cancer Science · 2024
DOI: 10.1111/cas.16068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Menghua Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of Minimally Invasive Hepatic Surgery, The First Affiliated Hospital of Ha…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Harbin Medical University Postgraduate Innovation and Practical Research Project, Scientific Foundation of the First Affiliated Hospital of Harbin Medical University, Heilongjiang Postdoctoral Foundation.
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and aggressive cancer whose incidence and mortality continue to increase, whereas its prognosis remains dismal. Tumor‐associated macrophages (TAMs) promote malignant progression and immune microenvironment remodeling through direct contact and secreted mediators. Targeting TAMs has emerged as a promising strategy for ICC treatment. Here, we revealed the potential regulatory function of immune responsive gene 1 (IRG1) in macrophage polarization. We found that IRG1 expression remained at a low level in M2 macrophages. IRG1 overexpression can restrain macrophages from polarizing to the M2 type, which results in inhibition of the proliferation, invasion, and migration of ICC, whereas IRG1 knockdown exerts the opposite effects. Mechanistically, IRG1 inhibited the tumor‐promoting chemokine CCL18 and thus suppressed ICC progression by regulating STAT3 phosphorylation. The intervention of IRG1 expression in TAMs may serve as a potential therapeutic target for delaying ICC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of Minimally Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Army Medical University, Chongqing, China.
- Department of Thyroid Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Hepatopancreatobiliary Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Department of General Surgery, The Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China.
- Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
ORCID-Profile: Menghua Zhou, Hongchi Jiang, Yong Ma
Förderung
- Harbin Medical University Postgraduate Innovation and Practical Research Project
- Scientific Foundation of the First Affiliated Hospital of Harbin Medical University
- Heilongjiang Postdoctoral Foundation
- China Postdoctoral Science Foundation
- Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province
- Natural Science Foundation of Heilongjiang Province of China
- National Natural Scientific Foundation of China
Zitieren
APA
Zhou, M., Yu, H., Bai, M., Lu, S., Wang, C., Ke, S., Huang, J., Li, Z., Xu, Y., Yin, B., Li, X., Feng, Z., Fu, Y., Jiang, H., & Ma, Y. (2024). IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18 / STAT3 pathway. Cancer Science. https://doi.org/10.1111/cas.16068
Vancouver
Zhou M, Yu H, Bai M, Lu S, Wang C, Ke S, et al. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18 / STAT3 pathway. Cancer Science. 2024. doi:10.1111/cas.16068
BibTeX
@article{Zhou2024,
author = {Zhou, Menghua and Yu, Hongjun and Bai, Miaoyu and Lu, Shounan and Wang, Chaoqun and Ke, Shanjia and Huang, Jingjing and Li, Zihao and Xu, Yanan and Yin, Bing and Li, Xinglong and Feng, Zhigang and Fu, Yao and Jiang, Hongchi and Ma, Yong},
title = {IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18 / STAT3 pathway},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16068}
}
EUVIMED